Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.

The results suggest that the immunosuppressive effects of NNK contribute to its high carcinogenic potency particularly in sustained or life-time exposure models, and hypothesize that sulindac promotes the recovery of immune system from the NNK-mediated suppression observed in the 7-week protocol.